A novel association of efavirenz induced severe cutaneous adverse reactions with HLA- DRB1*03:01: A case-control study from North-East India.

Singh, Mehak; Pawar, Manoj; Bhargava, Shashank; Gupta, Prakhar; Adhicari, Pankaj

Singh, Mehak; Pawar, Manoj; Bhargava, Shashank; Gupta, Prakhar; Adhicari, Pankaj.

Affiliation

Singh M; Department of Dermatology, LN Medical college and JK hospital, Bhopal, India.
Pawar M; Department of Dermatology, Varun Arjun Medical College, Shahajahanpur, U.P., India.
Bhargava S; Department of Dermatology, R. D. Gardi Medical College, Ujjain, India.
Gupta P; Department of General Medicine, LN Medical College and JK hospital, Bhopal, India.
Adhicari P; Department of Dermatology, Gauhati Medical College and Hospital, Guwahati, India.

Dermatol Ther ; 34(2): e14760, 2021 03.

Article in En | MEDLINE | ID: mdl-33421254

Subject(s)

Alkynes/adverse effects; Benzoxazines/adverse effects; Cyclopropanes/adverse effects; HIV Infections; HLA-DRB1 Chains; Case-Control Studies; Gene Frequency; HIV Infections/drug therapy; HIV Infections/genetics; HLA-DRB1 Chains/genetics; Humans; India

Key words

AGEP; AIDS; Efavirenz; HIV; SJS; TEN; drug rash; nevirapine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Cyclopropanes / Benzoxazines / Alkynes / HLA-DRB1 Chains Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2021 Type: Article Affiliation country: India

Fulltext

XML

PubMed Links

Search on Google